ArticleJournal of advanced research2026
High-throughput screening identifies FDA approved drug mitiglinide as a novel pyroptosis inhibitor and therapeutic agent for osteoarthritis.
Hanwen Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.